Oral urea therapy in sickle-cell anemia. A preliminary report.
D000284:Administration, Oral; D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy*; D001663:Bilirubin / Q000097:blood; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D004906:Erythrocyte Count; D005243:Feces / Q000032:analysis; D006242:Haptoglobins / Q000032:analysis; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006461:Hemolysis / Q000187:drug effects; D012156:Reticulocytes; D013997:Time Factors; D014508:Urea / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014558:Urobilinogen / Q000032:analysis
D006242:Haptoglobins; D006454:Hemoglobins; D014558:Urobilinogen; D014508:Urea; D003404:Creatinine; D001663:Bilirubin